BDBM107754 US8598217, 103
SMILES: COc1ccc(F)c(F)c1-c1cc(ccn1)C(=O)c1nc2ccc(cc2[nH]1)N1CCC(CC1)N(C)C
InChI Key: InChIKey=QFPALJFKLKEVNR-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cyclin-dependent kinase 4 (CDK4) (Oryctolagus cuniculus (Rabbit)) | BDBM107754 (US8598217, 103) | UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Astex Therapeutics Ltd.; Novartis AG US Patent | Assay Description A 384-well microtiter Lance TR-FRET (time-resolved-fluorescence energy transfer) endpoint assay was used for CDK4/cyclin D1 kinase activity measureme... | US Patent US8598217 (2013) BindingDB Entry DOI: 10.7270/Q2BG2MN8 | |||||||||||
More data for this Ligand-Target Pair |